Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.6000 (0.35%) ($42.6000 - $42.6000) on Fri. Dec. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 63 | Latest Price | $42.6000(0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 2.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(51%) IWM(49%) IWC(46%) ARKG(44%) | Factors Impacting HALO price | HALO will decline at least -1.63% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.03(1.36%) | 10 Day Moving Average | $41.48(2.7%) | 20 Day Moving Average | $40.83(4.34%) | To recent high | 0% | To recent low | 65.6% | Market Cap | $5.822b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |